Livent price target raised to $20 from $15 at Mizuho

Mizuho analyst John Roberts raised the firm’s price target on Livent (LTHM) to $20 from $15 and keeps a Neutral rating on the shares. The analyst says Allkem and Livent will merge into Arcadium Lithium (ALTM), the third largest global lithium producer after Albemarle and SQM. The all-stock deal “between these two unlevered firms leaves Arcadium with significant balance sheet flexibility to pursue continued growth,” the analyst tells investors in a research note. The firm says Arcadium will be more balanced between rock and brine resources.